Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000-2009: Multicenter study

Cancer Research and Treatment

Volumn 44, Issue 3, 2012, Pages 157-165

  Cho, Mee Yon ^a   Kim, Joon Mee ^b   Sohn, Jin Hee ^c   Kim, Mi Jung ^d,aa   Kim, Kyoung Mee ^c   Kim, Woo Ho ^e   Kim, Hyunki ^f   Kook, Myeong Cherl ^g   Park, Do Youn ^h   Lee, Jae Hyuk ⁱ   Chang, HeeKyung ^j   Jung, Eun Sun ^k   Kim, Hee Kyung ^l   Jin, So Young ^m   Choi, Joon Hyuk ⁿ   Gu, Mi Jin ^n,o   Kim, Sujin ^p   Kang, Mi Seon ^q   Cho, Chang Ho ^r   Park, Moon Il ^s   Kang, Yun Kyung ^q   Kim, Youn Wha ^t   Yoon, Sun Och ^u   Bae, Han Ik ^v   Joo, Mee ^w   Moon, Woo Sung ^x   Kang, Dae Young ^y   Chang, Sei Jin ^z   more..

^a Wonju Severance Christian Hospital   (South Korea)

^b Inha University Hospital   (South Korea)

^c Samsung Medical Center   (South Korea)

^d Asan Medical Center   (South Korea)

^e Seoul National University Hospital   (South Korea)

^f Yonsei University College of Medicine   (South Korea)

^g National Cancer Center   (South Korea)

^h Pusan National University Hospital   (South Korea)

ⁱ Chonnam National University Medical School   (South Korea)

^j Kosin University   (South Korea)

^k The Catholic University of Korea   (South Korea)

^l Soonchunhyang University   (South Korea)

^m Soonchunhyang University College of Medicine   (South Korea)

ⁿ Young Nam University Hospital   (South Korea)

^o Daegu Fatima Hospital   (South Korea)

^p Dong A University College of Medicine   (South Korea)

^q Inje University College of Medicine   (South Korea)

^r Catholic University of Daegu   (South Korea)

^s Konyang University College of Medicine   (South Korea)

^t Kyung Hee University College of Medicine   (South Korea)

^u Yonsei University College of Medicine   (South Korea)

^v Kyungpook National University Hospital   (South Korea)

^w Ilsanpaik Hospital   (South Korea)

^x Chonbuk National University Medical School   (South Korea)

^y Chungnam National University College of Medicine   (South Korea)

^z Yonsei University Wonju   (South Korea)

^aa Daehang Hospital   (South Korea)

more..

Author keywords

Gastro enteropancreatic neuroendocrine tumor; Incidence; Pathology; Prognosis

Indexed keywords

SYNAPTOPHYSIN;

ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; DISTANT METASTASIS; GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR; HUMAN; KOREA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; NEUROENDOCRINE TUMOR; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR VOLUME;

EID: 84874077720     PISSN: 15982998     EISSN: 20059256     Source Type: Journal    
DOI: 10.4143/crt.2012.44.3.157     Document Type: Article

References (25)

1. Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci. 2004;1014:13-27.
2. Kloppel G, Couvelard A, Perren A, Komminoth P, McNicol AM, Nilsson O, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology. 2009;90:162-6.
3. Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas. 2010;39:707-12.
4. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th ed. Lyon: International Agency for Research on Cancer; 2010.
5. Kloppel G, Rindi G, Anlauf M, Perren A, Komminoth P. Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Virchows Arch. 2007;451 Suppl 1:S9-27.
6. Boudreaux JP, Klimstra DS, Hassan MM, Woltering EA, Jensen RT, Goldsmith SJ, et al. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum. Pancreas. 2010;39:753-66.
7. Washington MK, Tang LH, Berlin J, Branton PA, Burgart LJ, Carter DK, et al. Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the colon and rectum. Arch Pathol Lab Med. 2010;134:176-80.
8. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471-4.
9. Klimstra DS, Modlin IR, Adsay NV, Chetty R, Deshpande V, Gonen M, et al. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol. 2010;34:300-13.
10. Vinik AI, Woltering EA, Warner RR, Caplin M, O'Dorisio TM, Wiseman GA, et al. NANETS consensus guidelines for the diagnosis of neuroendocrine tumor. Pancreas. 2010;39:713-34.
11. Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395-401.
12. Fritz A, Percy C, Jack A, Shanmugaratnam S, Sobin L, Parkin DM, et al. International classification of diseases for oncology (ICD-O). 3rd ed. Geneva: World Health Organization; 2000.
13. Maggard MA, O'Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240:117-22.
14. Garcia-Carbonero R, Capdevila J, Crespo-Herrero G, Diaz-Perez JA, Martinez Del Prado MP, Alonso Orduna V, et al. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE). Ann Oncol. 2010;21:1794-803.
15. Rothenstein J, Cleary SP, Pond GR, Dale D, Gallinger S, Moore MJ, et al. Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret Hospital. Am J Clin Oncol. 2008;31:64-70.
16. Ito T, Sasano H, Tanaka M, Osamura RY, Sasaki I, Kimura W, et al. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol. 2010;45:234-43.
17. Lee H, Choi J, An JS, Kim H, Shin BK, Kim A, et al. The clinicopathological characteristics of gastrointestinal neuroendocrine tumors: an analysis of 65 cases. Korean J Pathol. 2007;41: 149-57.
18. Chetty R. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology. Arch Pathol Lab Med. 2008;132:1285-9.
19. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
20. Arnold R. Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options. Best Pract Res Clin Gastroenterol. 2005;19:491-505.
21. Williams ED, Siebenmann RE, Sobin LH. Histological typing of endocrine tumours. Geneva: World Health Organization; 1980.
22. Colonoscopy Study Group of Korean Society of Coloproctology. Clinical characteristics of colorectal carcinoid tumors. J Korean Soc Coloproctol. 2011;27:17-20.
23. Jernman J, Valimaki MJ, Louhimo J, Haglund C, Arola J. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours. Neuroendocrinology. 2012;95:317-24.
24. Hirata I, Akutagawa H, Nishikawa T, Yasumoto S, Sanomura M, Egashira Y, et al. Clinicopathological study of colorectal carcinoid tumor, focusing on the indication for endoscopic mucosal resection (EMR). Stormach Intest. 2005;40:182-93.
25. Tabata H, Matsumoto T, Kuwano Y, Yao T, Iida M. Rectal carcinoid tumor 10 mm in diameter accompanied by multiple liver metastases, report of a case. Stormach Intest. 2005;40:215-20.